Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOCHA
NCT03088410Phase 4Completed
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Aug 2016
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of zidovudine and nevirapine in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Primary endpoint: Homeostatic Model Assessment-Insulin Resistance at 3 years. Started Aug 2016; status: completed.
02
Drugs
zidovudinenevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03088410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03088410.